Investing in Stocks Made Easy!
at ₹0 Brokerage with 5paisa.
+91
By proceeding, you agree to all T&C*
Investing in Stocks Made Easy!
We've sent a 6-digit verification code to +91 99123918232
Didn't receive the code? Resend
KILITCH

Kilitch Drugs(I) Share Price

 

 

Kilitch Drugs(I) live price: ₹183.06. It opened at ₹175 vs previous close ₹174; intraday high/low: ₹188/₹173. The 50 & 200 DMA stand at ₹155.87/₹167.30.

Kilitch Drugs(I) Performance

  • Today's Low
  • ₹173
  • Today's High
  • ₹188
  • 52 Week Low
  • ₹117
  • 52 Week High
  • ₹250
  • Open Price₹175
  • Previous Close₹174
  • Volume327,675
  • 50 DMA₹155.87
  • 100 DMA₹159.71
  • 200 DMA₹167.30

Kilitch Drugs(I) Chart

Investment Returns

  • Over 1 Month + 35.23%
  • Over 3 Month + 16.66%
  • Over 6 Month + 0.98%
  • Over 1 Year -20.62%

Smart Investing Starts Here Start SIP with Kilitch Drugs(I) for Steady Growth!

Invest Now

Kilitch Drugs(I) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.2
  • PEG Ratio
  • 1.5
  • Market Cap Cr
  • 640
  • P/B Ratio
  • 2.4
  • Average True Range
  • 10.39
  • EPS
  • 8.63
  • Dividend Yield
  • 0
  • MACD Signal
  • 4.41
  • RSI
  • 71.28
  • MFI
  • 96.43

Latest Stock News Updates

This small-cap pharma firm is eyeing a pie of the growing weight-loss drug market

Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is expanding its manufacturing capacity with a new facility in Khopoli, Maharashtra

US FDA Issues Warning Letter To Kilitch Healthcare For Navi-Mumbai Plant

The warning letter summarises significant violations of current good manufacturing practice regulations for finished pharmaceuticals at the Navi-Mumbai plant, which produces finished pharmaceuticals.

Kilitch Drugs Standalone December 2023 Net Sales at Rs 29.77 crore, up 4.43% Y-o-Y

Kilitch Drugs(I) Financials

Kilitch Drugs(I) Technicals

EMA & SMA

Current Price
₹183.06
-0.74 (-0.4%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹160.58
  • 50 Day
  • ₹155.87
  • 100 Day
  • ₹159.71
  • 200 Day
  • ₹167.30

Resistance and Support

183.9 Pivot Speed
  • R3 196.93
  • R2 192.87
  • R1 187.96
  • S1 178.99
  • S2 174.93
  • S3 170.02

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kilitch Drugs India has an operating revenue of Rs. 235.47 Cr. on a trailing 12-month basis. An annual revenue growth of 18% is outstanding, Pre-tax margin of 16% is great, ROE of 10% is good. The company has a reasonable debt to equity of 21%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 22% and 6% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 56 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kilitch Drugs(I) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-15 Audited Results
2026-02-11 Quarterly Results & Bonus issue
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results
2025-07-02 Others Inter-alia, to consider 1. Fund Raising by way of issue of equity shares of face value of 10/-each through Rights Issue. 2. Deployment of the proceeds of the Right Issue. 3. Other business matters. issue of equity shares of Rs. 10/- in the ratio of 2:23 @ premium of Rs. 347/-.
Date Purpose Remarks
2026-03-24 Bonus Rs.0.00 issue of equity shares in the ratio of 1:1 of Rs. 10/-.

Kilitch Drugs(I) Shareholding Pattern

63.77%
0%
0%
0%
0%
29.7%
6.53%

Kilitch Drugs(I) FAQs

Kilitch Drugs(I) share price is ₹183 As on 22 May, 2026 | 00:14

The Market Cap of Kilitch Drugs(I) is ₹640 Cr As on 22 May, 2026 | 00:14

The P/E ratio of Kilitch Drugs(I) is 21.2 As on 22 May, 2026 | 00:14

The PB ratio of Kilitch Drugs(I) is 2.4 As on 22 May, 2026 | 00:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23